Trial Profile
Therapeutic Effect of Ursodeoxycholic Acid on Duodenal Permeability and Meal Related Sensory Motor Function in Functional Dyspepsia Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Ursodeoxycholic acid (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- 09 Mar 2021 Status changed from recruiting to completed.
- 31 Dec 2016 New trial record